Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial

OBJECTIVE: Hypoglycemia is a frequent and potentially dangerous event among patients with diabetes mellitus type 1. Subcutaneous glucagon is an emergency treatment to counteract severe hypoglycemia. The effect of intraperitoneal glucagon delivery is sparsely studied. We performed a direct comparison...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Diabetes Res Care
Main Authors: Dirnena-Fusini, Ilze, Åm, Marte Kierulf, Fougner, Anders Lyngvi, Carlsen, Sven Magnus, Christiansen, Sverre Christian
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235059/
https://ncbi.nlm.nih.gov/pubmed/30487972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2018-000560
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados